Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jonathan Braverman

Showing results (11-20 of 14) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 14 results.
Genes & Development|August 17, 2019
MYC promotes tryptophan uptake and metabolism by the kynurenine pathway in colon cancerNiranjan Venkateswaran, M Carmen Lafita-Navarro, Yi-Heng Hao, et al.
Nature Communications|October 20, 2025
Leveraging platinum-protein interactions to overcome chemoresistanceFang Wang, Jonathan Braverman, George Eng, et al.
Iscience|May 17, 2021
Dickkopf-2 regulates the stem cell marker LGR5 in colorectal cancer via HNF4α1Jae Hun Shin, Jaekwang Jeong, Jungmin Choi, et al.
Nature Medicine|January 26, 2023
Combined PD-1, BRAF and MEK inhibition in BRAF<sup>V600E</sup> colorectal cancer: a phase 2 trialJun Tian, Jonathan H Chen, Sherry X Chao, et al.
Pageof 2

Showing results (11-20 of 14) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 14 results.
Genes & Development|August 17, 2019
MYC promotes tryptophan uptake and metabolism by the kynurenine pathway in colon cancerNiranjan Venkateswaran, M Carmen Lafita-Navarro, Yi-Heng Hao, et al.
Nature Communications|October 20, 2025
Leveraging platinum-protein interactions to overcome chemoresistanceFang Wang, Jonathan Braverman, George Eng, et al.
Iscience|May 17, 2021
Dickkopf-2 regulates the stem cell marker LGR5 in colorectal cancer via HNF4α1Jae Hun Shin, Jaekwang Jeong, Jungmin Choi, et al.
Nature Medicine|January 26, 2023
Combined PD-1, BRAF and MEK inhibition in BRAF<sup>V600E</sup> colorectal cancer: a phase 2 trialJun Tian, Jonathan H Chen, Sherry X Chao, et al.
Pageof 2